SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001213900-24-100972
Filing Date
2024-11-21
Accepted
2024-11-21 16:01:13
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO SCHEDULE 13G ea0221253-13ga2hafner_nls.htm SC 13G/A 74571
  Complete submission text file 0001213900-24-100972.txt   75906
Mailing Address THE CIRCLE 6 8058 ZURICH V8 CH-6370
Business Address THE CIRCLE 6 8058 ZURICH V8 CH-6370 41-41-618-80-00
NLS Pharmaceutics Ltd. (Subject) CIK: 0001783036 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92065 | Film No.: 241484166
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O NLS PHARMACEUTICS LTD. THE CIRCLE 6 ZURICH V8 8058
Business Address
Hafner Ronald (Filed by) CIK: 0002045580 (see all company filings)

Type: SC 13G/A